Skip to main content
. 2021 Oct;13(10):5617–5626. doi: 10.21037/jtd-21-1018

Table 3. Overall and progression-free survival by indicated year following baseline.

Inflammatory marker Overall survival, percentage (95% CI) Progression-free survival, percentage (95% CI)
1-Year 3-Year 5-Year 1-Year 3-Year 5-Year
NLR
   Q1 (≤2.1) 0.80 (0.72–0.85) 0.50 (0.41–0.59) 0.39 (0.28–0.49) 0.45 (0.36–0.54) 0.17 (0.11–0.26) 0.13 (0.06–0.22)
   Q2 (>2.1-3.0) 0.82 (0.74–0.87) 0.45 (0.36–0.53) 0.38 (0.29–0.47) 0.53 (0.44–0.62) 0.24 (0.16–0.32) 0.19 (0.12–0.28)
   Q3 (>3.0-4.1) 0.74 (0.66–0.80) 0.36 (0.28–0.45) 0.24 (0.16–0.33) 0.41 (0.32–0.50) 0.10 (0.05–0.17) 0.09 (0.04–0.15)
   Q4 (>4.1) 0.69 (0.61–0.76) 0.24 (0.16–0.31) 0.20 (0.13–0.29) 0.35 (0.27–0.44) 0.14 (0.08–0.22) 0.12 (0.06–0.20)

, back-transformed from logarithmic values. CI, confidence interval; Q, quartile.